Matthew L. Sherman, EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 2,360 shares at $12.02 ($28K) on 2023-10-30, disclosed to the SEC on 2023-10-31.
Seasonal sale ($28k) by EVP & Chief Medical Officer — this insider has traded DCPH in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |